Clinical significance of naturally occurring anti-zona pellucida antibodies in infertile women.

article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-06-12

Infertility patients with anti-zona pellucida antibodies who were treated for concurrent fertility issues achieved live births, suggesting these antibodies should not prevent such treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Although implicated in the etiology of unexplained infertility, a primary role for antibodies to zona pellucida antigens remains uncertain. We therefore prospectively studied 21 infertility patients found to have significant anti-zona pellucida antibody titers (1:4 to 1:16). When treated for endometriosis or other concurrent fertility problems, 7 of the 21 (33%) delivered viable infants. Two other patients conceived without treatment. Decreases in anti-zona antibody titers were found in most but not all women with successful outcomes. In a given individual, anti-zona antibodies may coexist with other fertility disorders. Therefore, these antibodies should not preclude treatment of concurrent fertility disorders.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Autoantibodies Infertility, Female Ovum Zona Pellucida Autoantibodies Endometriosis Endometriosis Endometriosis Female Humans Infertility, Female Ovum Pregnancy Pregnancy Outcome Prospective Studies Zona Pellucida

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-08-17T06:11:01.428247+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:25.758913+00:00
License: CC0 · commercial use OK